|
| Press Releases |
|
 |
|
| Thursday, August 24, 2023 |
|
|
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug |
| more info >> |
|
| Monday, July 31, 2023 |
|
|
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management |
| Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and Governance (ESG) evaluation report for China Medical System Holdings limited ("CMS" or the "Group"), who achieved an "AA" rating and surpassed 75% of global peers with leading ESG management practices. more info >> |
|
|
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management |
| Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and Governance (ESG) evaluation report for China Medical System Holdings limited ("CMS" or the "Group"), who achieved an "AA" rating and surpassed 75% of global peers with leading ESG management practices. more info >> |
|
| Thursday, June 29, 2023 |
|
|
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global |
| more info >> |
|
| Monday, June 12, 2023 |
|
|
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China |
| more info >> |
|
|
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China |
| more info >> |
|
| Tuesday, May 30, 2023 |
|
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
| On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
| On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
| Monday, December 19, 2022 |
|
|
Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets |
| Gelonghui released a Press Release on "China Medical System Holdings Limited's innovative product Methylthioninium Chloride Enteric-coated Sustained-release Tablets ('the Product') has obtained positive results for its Phase III clinical trial in China." more info >> |
|
| Friday, November 18, 2022 |
|
|
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally |
| Recently, the S&P Global Corporate Sustainability Assessment (S&P Global CSA) released the 2022 Environmental, Social and Governance (ESG) scores for China Medical System Holdings Limited ("CMS" or the "Group"). CMS achieved a significant improvement with a score of 53 in 2022 from 36 in 2021, surpassing 92% of the global peers and being significantly ahead of the industry average. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Xeleb Joins Miss Charm as Exclusive Web3 Partner to Revolutionize Voting and Judging with Decentralization
Dec 13, 2024 10:50 HKT/SGT
|
|
|
Asia Video Industry Association Wraps Up 2024 Harnessing the Power of Advertising to Spur the Industry Forward
Dec 13, 2024 10:35 HKT/SGT
|
|
|
Loop Industries Completes Convertible Preferred Financing With Reed Societe Generale Group and Sells First Technology License For An Infinite Loop Manufacturing Facility in Europe
Dec 13, 2024 09:10 HKT/SGT
|
|
|
Accurate Background Appoints Mark Thompson Managing Director, Australia and APAC
Dec 13, 2024 07:00 HKT/SGT
|
|
|
Notification of Dissolution of Joint Management of LT Metal Co., Ltd. by TANAKA Kikinzoku Kogyo K.K. and LT Corp.
Dec 13, 2024 4:00 JST
|
|
|
BBMSL与Yedpay HK强势联手推出全新品牌'AbbyPay'
Dec 12, 2024 22:35 HKT/SGT
|
|
|
Virturo Unveils Next-Gen CFD Trading Platform Empowered by AI and Human Expertise
Dec 12, 2024 22:30: JST
|
|
|
BBMSL與Yedpay HK強勢聯手推出全新品牌「AbbyPay」
Dec 12, 2024 22:30 HKT/SGT
|
|
|
Huatai Securities Hosts FinTech Summit in Hong Kong
Dec 12, 2024 22:25 HKT/SGT
|
|
|
Hong Kong's exports set for 4% growth in 2025
Dec 12, 2024 22:20 HKT/SGT
|
|
|
The Payment Cards Group Limited and Black Bear Merchant Services Limited Join Forces to Launch a New Brand 'AbbyPay'
Dec 12, 2024 22:10 HKT/SGT
|
|
|
慶祝安安可可到港 霸王茶姬聯合《HELLO PANDAS 熊貓駕到》戶外嘉年華
Dec 12, 2024 22:08 HKT/SGT
|
|
|
CIL Announces Breakthrough in Benzene Recovery, Addressing Cost, Environmental, and Supply Challenges for OLED Display Manufacturers
Dec 12, 2024 22:00 HKT/SGT
|
|
|
Virturo Unveils Next-Gen CFD Trading Platform Empowered by AI and Human Expertise
Dec 12, 2024 21:30 HKT/SGT
|
|
|
Brawijaya University develops data system for climate change monitoring
Dec 12, 2024 21:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
